Clinical endpoint
Top View
- A New Way to Evaluate Randomized Controlled Trials? New Approach Does More Harm Than Good
- Clinical Trial Designs for Non‐Traditional Antibiotics
- The Adaptive Concept Benefits of Adaptive Trials
- Proposed Primary Endpoints for Use in Clinical Trials That Compare Treatment Options for Bloodstream Infection in Adults: a Consensus Definition
- Multiple Endpoints in Clinical Trials
- PIES Method of Critique
- “Efficacy Trials of ZIKV Vaccines: Endpoints, Trial Design, Site Selection”
- Slowly Progressive, Low-Prevalence
- Reviewing Clinical Trials: a Guide for the Ethics Committee
- Of Adaptive Design Clinical Trials for Drugs and Biologics Guidance
- COVID-19: Developing Drugs and Biological Products for Treatment Or Prevention Guidance for Industry
- Applying Meta-Analytic-Predictive Priors with the R Bayesian Evidence Synthesis Tools
- Endpoints in Vaccine Trials
- The Roopfs Study to Assess Whether Improved Housing Provides
- OUTCOME MEASURES USED in CRITICAL CARE TRIALS Systematic Review Protocol
- Clinical Adjudication Committees: Best Practices for Use in a Range of Study Designs
- FDA Briefing Document Developing Antibacterial Therapies Targeting A
- Trial Designs and Endpoints